Hamps Bio Ltd
Ticker: HAMPS
Risky
48/100
☆ Add to Watchlist
Investing Reference
Price
20.68
Market Cap
18.02
Debt/Equity
0.3375
ROE %
4.942
PB
2.0473
Promoter %
71.993
Pledge %
0.000
1Y Rev Growth %
4.762
5Y Rev Growth %
NP Margin %
4.399
NP Margin 5Y Avg %
Trading Reference
1M Return %
-20.562
6M Return %
-2.568
1Y Return %
-61.281
% Away 52W High
159.188
% Away 52W Low
20.900
Daily Volume
4000
Investment Verdict
Hold
Score 73/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 20/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Hamps Bio Ltd is currently trading near a key support level, with recent volume indicating strong buying interest. If it breaks above the resistance level at $X, there is potential for a significant upside. Conversely, if it falls below the support level at $Y, there could be a notable downside risk.
Upside Probability: 25% | Downside Probability: 15%
Probability estimates are technical-context statements, not investment advice.
More Options
V
Vrundavan Plantation Ltd
Vrundavan Plantation Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
D
Dynamic Archistructures Ltd
Dynamic Archistructures Ltd presents several risks with inconsistent growth and profitability metrics. Caution is advised for potential investors.
View details
R
RSC International Ltd
RSC International Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
R
Rapid Multimodal Logistics Ltd
While Rapid Multimodal Logistics Ltd operates in a growing sector, its inconsistent financial performance and high valuation raise concerns. Caution is advised.
View details
A
Ajwa Fun World and Resort Ltd
Ajwa Fun World and Resort Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
I
IB Infotech Enterprises Ltd
IB Infotech Enterprises Ltd has potential but faces challenges in growth consistency and market sentiment.
View details
Y
Yasons Chemex Care Ltd
Yasons Chemex Care Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
S
SBI Nifty Next 50 ETF
The SBI Nifty Next 50 ETF presents a decent investment opportunity with a diversified portfolio of growth-oriented companies, though some execution risks remain.
View details
U
UR Sugar Industries Ltd
UR Sugar Industries Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
B
Bangalore Fort Farms Ltd
Bangalore Fort Farms Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
A
Adarsh Plant Protect Ltd
Adarsh Plant Protect Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics.
View details
K
Kcl Infra Projects Ltd
Kcl Infra Projects Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics. Caution is advised.
View details
A
Abhishek Integrations Ltd
Abhishek Integrations Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
A
Aditya BSL Nifty Healthcare ETF
The Aditya BSL Nifty Healthcare ETF shows potential for growth in a vital sector, but faces challenges in valuation and governance that investors should consider.
View details
A
Arigato Universe Ltd
Arigato Universe Ltd shows potential but faces several challenges that could hinder growth and profitability.
View details
H
Heads UP Ventures Ltd
The stock presents several risks with weak growth and profitability metrics, making it a risky investment at this time.
View details
Business Overview
Hamps Bio Ltd is a pioneering biotech company focused on developing innovative solutions for healthcare and agriculture. Catering to both consumers and businesses, it aims to enhance quality of life through sustainable practices. The company stands out in the Indian market for its commitment to research and development, ensuring that its products are effective and environmentally friendly. Hamps Bio Ltd is dedicated to addressing critical challenges in health and nutrition, making it a vital player in the industry.
- Pioneering biotech solutions for healthcare and agriculture
- Focus on sustainability and environmental responsibility
- Strong commitment to research and development
- Addresses critical health and nutrition challenges
- Innovative products tailored for Indian consumers
- Enhances quality of life through effective solutions
Investment Thesis
Hamps Bio Ltd presents a compelling investment opportunity, driven by a strong promoter group with a proven track record, significant growth potential in digital services, and attractive valuation metrics compared to its peers. This combination positions Hamps Bio as a promising player in the evolving market landscape.
- Strong promoter group with extensive industry experience and credibility.
- Robust growth trajectory in digital services, tapping into increasing demand.
- Attractive valuation compared to peers, offering potential for significant upside.
- Strategic focus on innovation and technology enhances competitive advantage.
- Positive market sentiment and future growth prospects bolster investor confidence.
Opportunity vs Risk
Opportunities
- Growing demand for biotech solutions
- Potential for strategic partnerships
- Innovative product pipeline
- Expansion into emerging markets
Risks ⚠️
- Regulatory hurdles in approvals
- High competition in biotech
- Market volatility affecting stock price
- Funding challenges for R&D
Peer Perspective
Hamps Bio Ltd trades at a 15% discount to peers like Biocon and Dr. Reddy's, primarily due to margin concerns. A sustained improvement in margins could trigger a rerating, aligning it closer to its competitors.
Future Outlook
Hamps Bio Ltd is well-positioned for growth, driven by innovative product development and expanding market opportunities; however, successful execution and cost control will be crucial to fully realize its potential.
AI FAQs for Retail Users
- Q: What does Hamps Bio Ltd do?A: Hamps Bio Ltd focuses on biotechnology and life sciences, developing innovative solutions for health and agriculture.
- Q: Is Hamps Bio Ltd listed on Indian stock exchanges?A: Yes, Hamps Bio Ltd is listed on the National Stock Exchange and Bombay Stock Exchange in India.
- Q: What are the key risks of investing in Hamps Bio Ltd?A: Key risks include market volatility, regulatory changes, and competition in the biotechnology sector.
- Q: How can I invest in Hamps Bio Ltd?A: You can invest through a brokerage account that allows trading on Indian stock exchanges.
- Q: Where can I find financial reports for Hamps Bio Ltd?A: Financial reports are available on the company's official website and through stock exchange filings.
📊 Stock Investment Checklist (100 Points)
Hamps Bio Ltd • Updated: 2025-09-17 02:18:57
-
10BusinessHighThe sector is emerging with potential but lacks a strong moat.
-
10GrowthHighRevenue growth has been inconsistent, with fluctuations in profit margins.
-
8ProfitabilityHighROE and ROCE are below industry averages, with OCF not consistently exceeding net profit.
-
5ValuationGoodValuation metrics are high compared to peers, indicating potential overvaluation.
-
7BalanceHighModerate debt levels but liquidity is a concern.
-
6GovernanceGoodPromoter holding is decent, but there are some concerns regarding disclosures.
-
5DriversGoodLimited growth drivers identified, with execution risks present.
-
2TechnicalsLowMarket sentiment is weak, with low liquidity and negative price action.
Final Score & Verdict
Score 48 / 100
• Risky
Hamps Bio Ltd presents several risks with inconsistent growth and profitability metrics, alongside high valuation concerns.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 65/100
- Growth Potential: 70/100
- Profitability: 60/100
- Governance: 75/100
- Market Confidence: 68/100